Diabetic Tussin C Interactions
There are 524 drugs known to interact with Diabetic Tussin C (codeine / guaifenesin), along with 16 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 125 are major, 396 are moderate, and 3 are minor.
- View all 524 medications that may interact with Diabetic Tussin C
- View Diabetic Tussin C alcohol/food interactions (1)
- View Diabetic Tussin C disease interactions (16)
Most frequently checked interactions
View interaction reports for Diabetic Tussin C (codeine / guaifenesin) and the medicines listed below.
- acetaminophen
- albuterol
- alendronate
- amiodarone
- amoxicillin / clavulanate
- Anbesol (benzocaine topical)
- aspirin
- bisacodyl
- calcium / vitamin d
- carbidopa / levodopa
- Claritin (loratadine)
- cyclobenzaprine
- diclofenac
- Diovan HCT (hydrochlorothiazide / valsartan)
- Diphen (diphenhydramine)
- Eliquis (apixaban)
- epinephrine
- Flonase (fluticasone nasal)
- fluconazole
- fluoxetine
- furosemide
- glimepiride
- glucose
- Humalog (insulin lispro)
- hydrocortisone
- ipratropium
- Januvia (sitagliptin)
- lamotrigine
- Lantus (insulin glargine)
- multivitamin
Diabetic Tussin C alcohol/food interactions
There is 1 alcohol/food interaction with Diabetic Tussin C (codeine / guaifenesin).
Diabetic Tussin C disease interactions
There are 16 disease interactions with Diabetic Tussin C (codeine / guaifenesin) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
Report options
More about Diabetic Tussin C (codeine / guaifenesin)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.